Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders.
Medtronic has recalled certain MiniMed insulin pumps due to cybersecurity risks, and will provide alternative pumps to the estimated 4,000 U.S. patients using the pumps, the Food and Drug Administration announced yesterday.
The Centers for Medicare & Medicaid Services’ proposed guidance for hospital co-location with other hospitals or health care facilities “represents an important update to existing CMS policy,” AHA said today.
Fewer than 40% of the U.S. population has been tested for HIV, the Centers for Disease Control and Prevention reported yesterday, although the agency recommends everyone aged 13-64 get tested at least once.
The AHA's American Organization for Nursing Leadership is accepting abstracts through Aug. 2 for its 2020 conference March 18-21 in Nashville, Tenn.
The Senate Judiciary Committee today passed four bills aimed at lowering prescription drug costs and increasing competition.
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.
Tax-exempt hospitals in the 340B drug savings program provided $56.1 billion in total benefits to their communities in 2016, the most recent year for which data is available, according to an analysis released today by the AHA.
A new report from the National Academies of Sciences, Engineering, and Medicine calls for a national strategy to reduce cancer incidence and mortality and improve quality of life for survivors.
The Centers for Medicare & Medicaid Services yesterday approved Louisiana’s Medicaid plan amendment allowing supplemental rebate agreement negotiations with prescription drug makers for Hepatitis C therapies.